Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Julphar
Chinese Patent Office
Novartis
US Army
Boehringer Ingelheim
Mallinckrodt
Deloitte
Citi
Daiichi Sankyo

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,352,803

« Back to Dashboard

Summary for Patent: 4,352,803
Title: Novel naphthyridine derivatives, intermediates thereof, processes for preparation thereof, and use thereof
Abstract:This invention relates to 1,8-naphthyridine compounds of the formula ##STR1## wherein X is a halogen atom especially fluorine atom, R.sub.1 is an ethyl group or a vinyl group, and R.sub.2 is a hydrogen atom or a lower alkyl group, their salts and processes for the preparation of them. The 1,8-naphthyridine compounds and their salts are useful as antibacterial agents and intermediates thereof.
Inventor(s): Matsumoto; Jun-ichi (Takatsuki, JP), Takase; Yoshiyuki (Amagasaki, JP), Nishimura; Yoshiro (Neyagawa, JP)
Assignee: Dainippon Pharmaceutical Co., Ltd. (Osaka, JP) Laboratoire Roger Bellon (Neuilly sur Seine, FR)
Application Number:06/264,824
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Use;

Drugs Protected by US Patent 4,352,803

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,352,803

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan53/104235Aug 25, 1978
Japan53/157939Dec 20, 1978
Japan53/162095Dec 29, 1978

International Patents Family Members for US Patent 4,352,803

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 223983 ➤ Sign Up
Argentina 225195 ➤ Sign Up
Argentina 227529 ➤ Sign Up
Australia 5004979 ➤ Sign Up
Australia 530052 ➤ Sign Up
Canada 1168241 ➤ Sign Up
Czechoslovakia 235502 ➤ Sign Up
Czechoslovakia 235545 ➤ Sign Up
Czechoslovakia 235546 ➤ Sign Up
German Democratic Republic 145753 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
QuintilesIMS
Johnson and Johnson
Accenture
Queensland Health
Medtronic
Cipla
Fish and Richardson
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot